Eisai Co., Ltd. and nippon medac Co., Ltd., a subsidiary of medac group announced today that they have launched the anti-rheumatic agent "Metoject Subcutaneous Injection ...

Methotrexate is one of the oldest and most cost-effective medicines available for rheumatoid arthritis (RA). Its also one of the most commonly used RA therapies. Heres what to know about this drug if ...

France and parts of the UK face another heatwave. Store medicines properly, stay hydrated, and protect heat-sensitive drugs.

Transformative delivery option that may support earlier management of worsening fluid overload with a self-administered option designed for use ...

Furoscix ReadyFlow demonstrated a bioavailability of 107.3% relative to IV furosemide, with comparable diuresis, natriuresis, and kaliuresis at 6, 8, and 12 hours postdose. The Food and Drug ...

The Furoscix ReadyFlow auto-injector [Image courtesy of MannKind] MannKind (Nasdaq:MNKD) announced today that it secured $50 million in a private placement and earned a new regulatory nod. In addition ...

Along with Dr. John H. Stone, Dr. Eric L. Matteson is responsible for this section on less common vasculitides. His credentials are: MD, professor of medicine at the Mayo Clinic, and he is taking over ...

From the Department of Cardiology and Angiology I, University Heart Center Freiburg, Germany (D.W.) Faculty of Medicine, University of Freiburg, Germany (D.W.) K. Ley has received research funding for ...